All publications of “Pedro Luiz Serrano Usón Junior”

2 results

Higher overall survival in metastatic pancreatic cancer: the impact of where and how treatment is delivered

Pedro Luiz Serrano Usón Junior, Monique Sedlmaier França, Heloisa Veasey Rodrigues, Antônio Luiz de Vasconcellos Macedo, Alberto Goldenberg, Oren Smaletz, [...]

DOI: 10.1590/S1679-45082015AO3303

ObjectiveTo determine the overall survival of patients with advanced pancreatic cancer and evaluate factors that impact prognosis in a private cancer center.MethodsData from the Hospital Cancer Registry at Hospital Israelita Albert Einstein were retrospectively collected. The patients enrolled had metastatic cancer at diagnosis or earlier staging and subsequent recurrence. Cases of neuroendocrine tumors were excluded.ResultsA total of 65 patients were evaluated, including 63 with adenocarcinoma. The median overall survival for patients in all stages was 20.7 months (95%CI: 15.6-25.7), while […]

Assessment of adherence to the guidelines for the management of nausea and vomiting induced by chemotherapy

Monique Sedlmaier França, Pedro Luiz Serrano Usón Junior, Yuri Philippe Pimentel Vieira Antunes, Bernard Lobato Prado, Carlos del Cistia Donnarumma, Taciana Sousa Mutão, [...]

DOI: 10.1590/S1679-45082015AO3097

ABSTRACTObjective:To assess adherence of the prescribing physicians in a private cancer care center to the American Society of Clinical Oncology guideline for antiemetic prophylaxis, in the first cycle of antineoplastic chemotherapy.Methods:A total of 139 chemotherapy regimens, of 105 patients, were evaluated retrospectively from 2011 to 2013.Results:We observed 78% of non-adherence to the guideline rate. The main disagreements with the directive were the prescription of higher doses of dexamethasone and excessive use of 5-HT3 antagonist for low risk emetogenic chemotherapy regimens. […]